Role of Nanobiotechnology in Developing Personalized Medicine for Cancer

Feeds:: Posts; Comments

« UNESCO Calls for More Regulations on Genome Editing, DTC Genetic Testing

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine »

Role of Nanobiotechnology in Developing Personalized Medicine for Cancer

October 8, 2015 by larryhbern

Role of Nanobiotechnology in Developing Personalized Medicine for Cancer

Writer and Curator: Larry H Bernstein, MD, FCAP

3.2 Role of Nanobiotechnology in Developing Personalized Medicine for Cancer

K. K. Jain
Technol Cancer Res Treat Dec 2005; 4(6): 645-650

http://dx.doi.org:/10.1177/153303460500400608

Personalized medicine simply means the prescription of specific therapeutics best suited for an individual. Personalization of cancer therapies is based on a better understanding of the disease at the molecular level. Nanotechnology will play an important role in this area. Nanobiotechnology is being used to refine discovery of biomarkers, molecular diagnostics, drug discovery and drug delivery, which are important basic components of personalized medicine and are applicable to management of cancer as well. Examples are given of the application of quantum dots, gold nanoparticles, and molecular imaging in diagnostics and combination with therapeutics – another important feature of personalized medicine. Personalized medicine is beginning to be recognized and is expected to become a part of medical practice within the next decade. Personalized management of cancer, facilitated by nanobiotechnology, is expected to enable early detection of cancer, more effective and less toxic treatment increasing the chances of cure.